Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.1936 (-0.97%) ($6.0000 - $6.2480) on Sun. Dec. 22, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.72% (three month average) | RSI | 49 | Latest Price | $6.1936(-0.97%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EYES price | EYES will decline at least -1.86% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.86% (StdDev 3.72%) | Hourly BBV | 0 () | Intraday Trend | 1.9% | | | |
|
1 - 5 Day Possible Target | $-4.99(-180.57%) | Resistance Level | $6.53 | 5 Day Moving Average | $6.2(-0.1%) | 10 Day Moving Average | $6.25(-0.9%) | 20 Day Moving Average | $6.53(-5.15%) | To recent high | -15.7% | To recent low | 6.7% | Market Cap | $N/A | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |